| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $463.5M | -6.6% |
| Cost of Revenue | $129.5M | +17.8% |
| Gross Profit | $334.0M | -13.5% |
| R&D Expense | $118.5M | -1.7% |
| SG&A Expense | $140.5M | +21.9% |
| Operating Income | -$1.85B | -1510.6% |
| Pre-tax Income | -$1.93B | -1453.4% |
| Income Tax | -$767.7M | -38.7% |
| Net Income | -$1.17B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.1M | -18.6% |
| Accounts Receivable | $181.2M | -1.4% |
| Current Assets | $252.3M | -5.8% |
| Total Assets | $25.84B | +442.6% |
| Current Liabilities | $355.4M | +9.9% |
| Long-term Debt | $7.19B | +229.6% |
| Total Liabilities | $7.61B | +193.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.0M | -517.2% |
| Capital Expenditures | $3.0M | +1.4% |
| Investing Cash Flow | -$22.09B | -1059.2% |
| Financing Cash Flow | $22.13B | +1071.1% |
| Free Cash Flow | -$56.0M | -673.1% |
| -371.9% |
| EPS (Basic) | -$6.06 | -119.3% |
| EPS (Diluted) | -$6.06 | -122.9% |
| Stockholders' Equity |
| $18.23B |
| +742.0% |